University Hospital Bonn Department of Surgery
Related items
Trial Projects:
- Postoperative Ileus: Duration and Severity Assessment With the SmartPill® (PIDuSA)
- Ranibizumab In Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration Study (RIP)
- Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients (CeTeG)
- Chromoendoskopie versus konventionelle Endoskopie bei Patienten mit Polyposis-Erkrankungen (ChroPol)
- A multicenter, open label, single-arm pilot study to evaluate the efficacy and safety of guselkumab in patients with moderate to severe palmoplantar pustulosis (PPP)
- Echtzeit-Nutzung von automatisierter Intelligenz (CADEYE) bei der Darmkrebs-Überwachung von Patienten mit Lynch-Syndrom
Institutions: University Hospital Bonn Department of Surgery, University Hospital Bonn Department of Ophthalmology, Default Institution
Postoperative ileus (POI) is a frequent complication after abdominal surgery leading to nausea, vomiting and infectious complications. Bowel dysmotility can last for days and necessitates parenteral nutrition resulting in an prolonged hospital stay and a high economic burden.
Until now there is no evidence based therapy of manifest POI because of missing valid surrogate markers demonstrating the severity and resolution of POI.
A novel tool to examine gastrointestinal function is the SmartPill®. ...
Public web page: https://clinicaltrials.gov/study/NCT02329912
Start date: 1st Dec 2014
End date: 31st Dec 2016
Demonstration of improvement in moderate to se-vere chronic PPP after guselkumab administration Evaluation of efficacy and safety of guselkumab application in patients with moderate to severe PPP Determination of improvement of quality of life due to guselkumab administration in patients with moderate to severe PPP Demonstration of improvement in moderate to severe chronic PPP after guselkumab administration
This Trial contains a sub-study with the following related objectives Exploration of the ...
Public web page: https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004451-20/DE
Start date: 17th Jul 2019
End date: 20th Jul 2021
